These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2917110)

  • 21. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
    Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.
    Schneider JJ; Ravenscroft PJ; Cavenagh JD; Brown AM; Bradley JP
    Br J Clin Pharmacol; 1992 Nov; 34(5):431-3. PubMed ID: 1467139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
    Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
    Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients.
    Ihmsen H; Schüttler J; Jeleazcov C
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients.
    Ashby M; Fleming B; Wood M; Somogyi A
    J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
    Hasselström J; Säwe J
    Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration.
    Bigler D; Christensen BC; Eriksen J; Jensen HN
    Pain; 1990 Apr; 41(1):15-18. PubMed ID: 2352761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of halothane on morphine disposition: relative contributions of the liver and kidney to morphine glucuronidation in the dog.
    Merrell WJ; Gordon L; Wood AJ; Shay S; Jackson EK; Wood M
    Anesthesiology; 1990 Feb; 72(2):308-14. PubMed ID: 2301762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.
    Hain RD; Hardcastle A; Pinkerton CR; Aherne GW
    Br J Clin Pharmacol; 1999 Jul; 48(1):37-42. PubMed ID: 10383558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal kinetics of morphine during labour.
    Gerdin E; Salmonson T; Lindberg B; Rane A
    J Perinat Med; 1990; 18(6):479-87. PubMed ID: 2097341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine-6-glucuronide disposition in renal impairment.
    Hanna MH; D'Costa F; Peat SJ; Fung C; Venkat N; Zilkha TR; Davies S
    Br J Anaesth; 1993 May; 70(5):511-4. PubMed ID: 8318321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of blood sample preparation on measured levels of morphine and its major metabolites.
    Hoskin PJ; Alsayed-Omar O; Hanks GW; Johnston A; Turner P
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():182-4. PubMed ID: 2729862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
    Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
    Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of morphine-6-glucuronide in street heroin addicts.
    Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
    Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.
    Samuelsson H; Hedner T; Venn R; Michalkiewicz A
    Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.
    Aasmundstad TA; Mørland J; Paulsen RE
    J Pharmacol Exp Ther; 1995 Oct; 275(1):435-41. PubMed ID: 7562582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.
    Peterson GM; Randall CT; Paterson J
    Eur J Clin Pharmacol; 1990; 38(2):121-4. PubMed ID: 2338107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.
    Klepstad P; Hilton P; Moen J; Kaasa S; Borchgrevink PC; Zahlsen K; Dale O
    BMC Clin Pharmacol; 2004 Oct; 4():7. PubMed ID: 15461818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.